Evidence map›Paper›PMID 35943791›Full record

ArticleJMIR cancer2022

Deploying the Behavioral and Environmental Sensing and Intervention for Cancer Smart Health System to Support Patients and Family Caregivers in Managing Pain: Feasibility and Acceptability Study.

Virginia LeBaron, Ridwan Alam, Rachel Bennett, Leslie Blackhall, Kate Gordon, James Hayes, Nutta Homdee, Randy Jones, Kathleen Lichti, Yudel Martinez and 4 more

Open access · goldAbstract read
In one paragraph

Article in JMIR cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Virginia LeBaronUniversity of Virginia School of Nursing, Charlottesville, VA, United States.ORCID https://orcid.org/0000-0002-1299-4730
Ridwan AlamMassachusetts Institute of Technology, Cambridge, MA, United States.ORCID https://orcid.org/0000-0002-4332-4051
Rachel BennettUniversity of Virginia School of Nursing, Charlottesville, VA, United States.ORCID https://orcid.org/0000-0002-6486-1673
Leslie BlackhallUniversity of Virginia School of Medicine, Charlottesville, VA, United States.ORCID https://orcid.org/0000-0002-7536-1658
Kate GordonVirginia Commonwealth University Health, Richmond, VA, United States.ORCID https://orcid.org/0000-0003-2555-5128
James HayesTrident Systems, Inc, Fairfax, VA, United States.ORCID https://orcid.org/0000-0002-6918-3381
Nutta HomdeeFaculty of Medical Technology, Mahidol University, Nakhon Pathom, Thailand.ORCID https://orcid.org/0000-0003-3845-6559
Randy JonesUniversity of Virginia School of Nursing, Charlottesville, VA, United States.ORCID https://orcid.org/0000-0002-2739-5132
Kathleen LichtiUniversity of Virginia School of Nursing, Charlottesville, VA, United States.ORCID https://orcid.org/0000-0003-1363-3854
Yudel MartinezUniversity of Virginia School of Engineering & Applied Science, Charlottesville, VA, United States.ORCID https://orcid.org/0000-0002-5671-4614
Sahar MohammadiPenn Medicine, University of Pennsylvania Health System, Philadelphia, PA, United States.ORCID https://orcid.org/0000-0002-0428-6750
Emmanuel OgunjirinUniversity of Virginia School of Engineering & Applied Science, Charlottesville, VA, United States.ORCID https://orcid.org/0000-0001-8458-3204
Nyota PatelUniversity of Virginia School of Engineering & Applied Science, Charlottesville, VA, United States.ORCID https://orcid.org/0000-0003-3695-8969
John LachThe George Washington University School of Engineering & Applied Science, Washington, DC, United States.ORCID https://orcid.org/0000-0002-7105-9996
University of Virginia · USGeorge Washington University · USMahidol University · THMassachusetts Institute of Technology · USTrident Systems (United States) · USUniversity of Pennsylvania Health System · USVirginia Commonwealth University · US

Funding

Characterizing the Complexity of Advanced Cancer Pain in the Home Context by Leveraging Smart Health TechnologyR01NR019639 · NINR · UNIVERSITY OF VIRGINIA · PI LEBARON, VIRGINIA TOWNSEND · 2021 to 2025
$3.4M
NINR NIH HHS R01 NR019639
6 · The paper itself

Abstract

backgroundDistressing cancer pain remains a serious symptom management issue for patients and family caregivers, particularly within home settings. Technology can support home-based cancer symptom management but must consider the experience of patients and family caregivers, as well as the broader environmental context.

objectiveThis study aimed to test the feasibility and acceptability of a smart health sensing system-Behavioral and Environmental Sensing and Intervention for Cancer (BESI-C)-that was designed to support the monitoring and management of cancer pain in the home setting.

methodsDyads of patients with cancer and their primary family caregivers were recruited from an outpatient palliative care clinic at an academic medical center. BESI-C was deployed in each dyad home for approximately 2 weeks. Data were collected via environmental sensors to assess the home context (eg, light and temperature); Bluetooth beacons to help localize dyad positions; and smart watches worn by both patients and caregivers, equipped with heart rate monitors, accelerometers, and a custom app to deliver ecological momentary assessments (EMAs). EMAs enabled dyads to record and characterize pain events from both their own and their partners' perspectives. Sensor data streams were integrated to describe and explore the context of cancer pain events. Feasibility was assessed both technically and procedurally. Acceptability was assessed using postdeployment surveys and structured interviews with participants.

resultsOverall, 5 deployments (n=10 participants; 5 patient and family caregiver dyads) were completed, and 283 unique pain events were recorded. Using our "BESI-C Performance Scoring Instrument," the overall technical feasibility score for deployments was 86.4 out of 100. Procedural feasibility challenges included the rurality of dyads, smart watch battery life and EMA reliability, and the length of time required for deployment installation. Postdeployment acceptability Likert surveys (1=strongly disagree; 5=strongly agree) found that dyads disagreed that BESI-C was a burden (1.7 out of 5) or compromised their privacy (1.9 out of 5) and agreed that the system collected helpful information to better manage cancer pain (4.6 out of 5). Participants also expressed an interest in seeing their own individual data (4.4 out of 5) and strongly agreed that it is important that data collected by BESI-C are shared with their respective partners (4.8 out of 5) and health care providers (4.8 out of 5). Qualitative feedback from participants suggested that BESI-C positively improved patient-caregiver communication regarding pain management. Importantly, we demonstrated proof of concept that seriously ill patients with cancer and their caregivers will mark pain events in real time using a smart watch.

conclusionsIt is feasible to deploy BESI-C, and dyads find the system acceptable. By leveraging human-centered design and the integration of heterogenous environmental, physiological, and behavioral data, the BESI-C system offers an innovative approach to monitor cancer pain, mitigate the escalation of pain and distress, and improve symptom management self-efficacy. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/16178.

Indexed as

cancerfamily caregiverfeasibility and acceptabilitymHealthmobile healthpainpalliative careremote monitoringruralsmart health

Identifiers

PMID35943791
PMCPMC9399893
OpenAlexW4283798622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.